We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

26 hedge funds and large institutions have $784K invested in Cocrystal Pharma in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

4% more capital invested

Capital invested by funds: $754K → $784K (+$29.4K)

0.04% more ownership

Funds ownership: 5.59% → 5.63% (+0.04%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

7% less funds holding

Funds holding: 28 → 26 (-2)

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$21.6K
2
VF
Virtu Financial
New York
+$13.5K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$7.98K
4
Wells Fargo
Wells Fargo
California
+$6.45K
5
UBS Group
UBS Group
Switzerland
+$2.96K

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$32.9K
2
Bank of America
Bank of America
North Carolina
-$8.89K
3
FFO
Fortitude Family Office
Arizona
-$3.15K
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.17K
5
TRCT
Tower Research Capital (TRC)
New York
-$877
Name Holding Trade Value Shares
Change 		Change in
Stake
VCM
1
Vanguard Capital Management
Pennsylvania
$242K +$248K +239,971 New
Renaissance Technologies
2
Renaissance Technologies
New York
$125K -$2.17K -2,100 -2%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$91.1K +$7.98K +7,732 +9%
BlackRock
4
BlackRock
New York
$74.5K – – –
TC
5
T3 Companies
New York
$52K -$825 -800 -2%
XT
6
XTX Topco
Cayman Islands
$36.4K +$21.6K +20,890 +138%
Neuberger Berman Group
7
Neuberger Berman Group
New York
$32.2K – – –
VFT
8
Vanguard Fiduciary Trust
Pennsylvania
$24.3K +$24.8K +24,016 New
State Street
9
State Street
Massachusetts
$20.7K – – –
TSS
10
Two Sigma Securities
New York
$15.4K +$2.58K +2,503 +20%
VF
11
Virtu Financial
New York
$13K +$13.5K +13,080 New
Jane Street
12
Jane Street
New York
$12.8K +$2.15K +2,085 +20%
PA
13
Parallel Advisors
California
$12.7K – – –
Northern Trust
14
Northern Trust
Illinois
$12K – – –
Wells Fargo
15
Wells Fargo
California
$7.11K +$6.45K +6,251 +793%
UBS Group
16
UBS Group
Switzerland
$4.69K +$2.96K +2,867 +161%
TRCT
17
Tower Research Capital (TRC)
New York
$4.29K -$877 -850 -17%
Morgan Stanley
18
Morgan Stanley
New York
$957 – – –
Northwestern Mutual Wealth Management
19
Northwestern Mutual Wealth Management
Wisconsin
$825 – – –
CYG
20
Clean Yield Group
Vermont
$422 – – –
Fidelity Investments
21
Fidelity Investments
Massachusetts
$337 +$345 +334 New
MCM
22
MAI Capital Management
Ohio
$240 – – –
NL
23
NVWM LLC
Pennsylvania
$85 – – –
SS
24
SBI Securities
Japan
$33 – – –
Citigroup
25
Citigroup
New York
$1 -$401 -389 -100%
1
2

COCP Hedge Fund Activity: Q1 2026 in Review

26 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q1 2026, worth a combined $784K — up 3.9% from $754K a quarter earlier.

Fund positioning in COCP was balanced in Q1 2026: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 4 trimmed.

The largest buyer was XTX Topco, adding an estimated $21.6K. The largest seller was DRW Securities, exiting entirely with an estimated $32.9K sold.

  • 26 institutional investors held Cocrystal Pharma (COCP) as of Q1 2026, down from 28 in Q4 2025.
  • Funds reported $784K of Cocrystal Pharma stock for Q1 2026, up 3.9% quarter-over-quarter.
  • 4 funds opened new Cocrystal Pharma positions in Q1 2026 and 4 closed out, a net change of 0 holders.
  • The largest Cocrystal Pharma buyer in Q1 2026 was XTX Topco, an estimated $21.6K added.
  • The largest Cocrystal Pharma seller in Q1 2026 was DRW Securities, an estimated $32.9K sold.

Based on aggregated 13F filings for Q1 2026.